Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose is to investigate daptomycin pharmacokinetics in critically ill patients with
suspected or verified bacteremia with Gram-positive cocci undergoing combined continuous
hemodiafiltration at a filtration rate of 35ml/kg/h and to establish a dose recommendation
for continuous hemodiafiltration at a filtrate rate of 35ml/kg/h.